Becton dickinson BD max consumables
Ended Awarded Last action
- Contract number
- W9114F25FA002
- Awardee
-
Becton, Dickinson Italia S.P.A. UEI GYGHXGHBXDL6 Part of Becton, Dickinson And Co
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $15,675
Award facts
- Contract value 97% obligated
- $16,162.05 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 621511 Medical Laboratories
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Italy
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$10,960 | |
| Original award | $26,636 |
About this award
The Defense Health Agency awarded a Blanket Purchase Agreement (BPA) call valued at $16,162.05 to Becton, Dickinson Italia S.P.A. on March 1, 2025, for BD MAX System consumables and microbiological culture products. This firm fixed-price award, with an ultimate completion date of February 28, 2029, represents a task order issued under the vendor's existing single-award BPA with the Defense Health Agency (effective March 1, 2024 through February 28, 2029, with a $249,000 ceiling). Performance will be conducted in Italy, leveraging the vendor's manufacturing and distribution capabilities to supply diagnostic testing consumables compatible with the BD MAX automated diagnostic platform. The award carries no small business set-aside designation. Becton, Dickinson Italia S.P.A. is an Italian subsidiary of Becton, Dickinson and Company, a global medical technology manufacturer headquartered in New Jersey that specializes in diagnostic equipment, laboratory products, and related consumables.
This BPA call supports laboratory diagnostic operations at U.S. military medical treatment facilities in Europe, including the U.S. Army Health Center in Vicenza and U.S. Navy Hospital locations. The parent company, Becton, Dickinson and Company, maintains an extensive federal contract portfolio across multiple healthcare agencies, including substantial Indefinite Delivery Vehicle agreements with the Department of Veterans Affairs and Defense Logistics Agency. The BPA vehicle has demonstrated sustained demand, having generated approximately $290,000 in cumulative task order awards against the $249,000 ceiling since its establishment, reflecting critical ongoing requirements for microbiological identification and susceptibility testing capabilities within the military healthcare system.
Quick answers
Who was awarded contract W9114F25FA002?
W9114F25FA002 was awarded to Becton, Dickinson Italia S.P.A. by Medical Command (Department of the Army) on March 1, 2025.
How much is contract W9114F25FA002 worth?
The government has obligated $15,675 on W9114F25FA002. Its current value, with exercised options, is $16,162.
Which agency awarded contract W9114F25FA002?
Medical Command (Department of the Army) awarded W9114F25FA002, with funding from Defense Health Agency (Department of Defense).
Is contract W9114F25FA002 an order under another contract?
Yes. W9114F25FA002 is a BPA call under W9114F24A0002, a blanket purchase agreement.
Was contract W9114F25FA002 competed?
The extent of competition for W9114F25FA002 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award